Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine

Rahul Misra1, Siddhant Sharma2, Manjit Haer2

  • 1Vaccine CMC Development and Supply, Analytical Sciences, Sanofi, Toronto, M2R 3T4, Canada. Rahul.misra@sanofi.com.

Abstract

Related Concept Videos